Has Robert Tashjian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,556,984 in general payments to Robert Tashjian, MD across 556 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Tashjian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Tashjian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Tashjian, MD

Orthopaedic Surgery · Salt Lake City, UTNPI 1659300044

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,808,352 of the $2,556,984 with a category attached, or 70.7%. Stryker accounts for 82.5% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $891,909, more than ten times the $28,515 reported in 2019. Among orthopaedic surgery clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,556,984in general payments, 2019–2025

Across 556 payments — averaging $4598.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$2.1M
Johnson & Johnson$193K
Shoulder Innovations, Inc.$164K
Zimmer Biomet$73K
Encore Medical, LP$10K
Depuy Synthes Products, Inc.$6K
plus $3K from 4 others

$471,421in research payments, 2019–2025

Across 52 payments — averaging $9065.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$436K
Zimmer Biomet$26K
Osteoremedies, LLC$9K

What the payments were for

Royalty or licence$1,808,35271%
Consulting fees$460,86018%
Speaking & faculty fees$14,4431%
Travel & lodging$68,3833%
Food & beverage$9,2930%
Education$2,7410%
Other$192,9138%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	484	$2,108,641
Johnson & Johnson	2	$192,913
Shoulder Innovations, Inc.	28	$164,445
Zimmer Biomet	25	$72,871
Encore Medical, LP	4	$9,849
Depuy Synthes Products, Inc.	5	$5,715
Active Medical, LLC	2	$1,400
Synthes GmbH	4	$1,062
Medical Device Business Services, Inc.	1	$64
Medacta USA, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AEQUALIS PERFORM$853,584
AEQUALIS PERFORM REVERSED$685,198
TORNIER PERFORM REVERSED GLENOID$414,947
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$259,601
InSet System$120,988
TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$116,767
TORNIER PERFORM REVERSED AUGMENTED GLENOID$95,564
SIMPLICITI$51,059
Biowick$48,672
AEQUALIS$27,832
REUNION$26,633
BioWick X$24,185
Shoulder Innovations Humeral Short Stem System$18,428
INSIGNIA$11,660
MAKO$11,660
TORNIER FLEX$10,070
BLUEPRINT PSI SYSTEM$8,480
R&D UPPER EXT$8,083
AEQUALIS ASCEND FLEX$6,623
AEQUALIS REVERSED II$6,360

How this compares

$2,556,984 in reported general payments places this provider in the 95th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah →

Medicare billing

Part B allowed, 2024

$208,865

Medicare patients

339

Services billed

970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox	36	$2,153
Celecoxib	18	$177
Pregabalin	17	$100
Oxycodone Hcl	18	$76
Tramadol Hcl	14	$29
Amoxicillin	18	$20

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Salt Lake City

Aaron HofmannSalt Lake City$10.7M
Jeremy GilillandSalt Lake City$2.9M
Jeffrey JacksonSalt Lake City$2.3M
Thomas HigginsSalt Lake City$1.2M
Christopher MartinSalt Lake City$1.2M
Christopher PeltSalt Lake City$432K
Robert BurksSalt Lake City$355K
Charles SaltzmanSalt Lake City$254K
Stephen AokiSalt Lake City$239K
Brandon LawrenceSalt Lake City$144K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →